Skip to content
Shuttingdown

Propanc Biopharma, Inc.

Pharmaceutical Preparations · CAMBERWELL, VICTORIA

Distress signal

Moderate confidence (50%)

Updated Oct 7, 2026, 12:04 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: Propanc Biopharma, Inc. received a delisting notice from its exchange (Dec 31, 2025)

Timeline

Every material event, newest first. History is never overwritten.

  1. Propanc Biopharma, Inc. received a delisting notice from its exchange

    Dec 31, 2025

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On December 31, 2025, Propanc Biopharma, Inc. (the Company ) received a written notice (the Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market ( Nasdaq ) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the Bid Price Requirement ). The Notice does not result in the immediate delisting of the Company s common stock from…”

Company information

Founded
—
Employees (estimate)
—
Industry
Pharmaceutical Preparations
Subindustry
—
Listing
SEC lists the ticker PPCB on Nasdaq.
SEC CIK
0001517681
Website
—
LinkedIn
—
Headquarters
CAMBERWELL, VICTORIA
Also known as
Propanc Health Group Corp
Legal entities
Propanc Biopharma, Inc.

Sources

Every material source used to build this profile.

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    Propanc Biopharma, Inc. — Pharmaceutical Preparations (SIC 2834) — CAMBERWELL, VICTORIA, Australia
    View source record
  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On December 31, 2025, Propanc Biopharma, Inc. (the Company ) received a written notice (the Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market ( Nasdaq ) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the Bid Price Requirement ). The Notice does not result in the immediate delisting of the Company s common stock from…
    View source record

Status history

Every derived status, with the rule that produced it.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:31 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:12 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:32 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:46 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:54 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.